Paroxetine Hydrochloride



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Depression 33.8%
Product Used For Unknown Indication 25.7%
Drug Use For Unknown Indication 11.8%
Anxiety 10.0%
Major Depression 3.9%
Hypertension 2.0%
Obsessive-compulsive Disorder 1.7%
Insomnia 1.5%
Panic Disorder 1.3%
Post-traumatic Stress Disorder 1.1%
Stress 0.9%
Cauda Equina Syndrome 0.8%
Emotional Distress 0.8%
Essential Hypertension 0.8%
Panic Attack 0.8%
Asthma 0.7%
Bipolar Disorder 0.7%
Fatigue 0.7%
Generalised Anxiety Disorder 0.7%
Anxiety Disorder 0.5%
Suicidal Ideation 18.3%
Withdrawal Syndrome 17.6%
Ventricular Septal Defect 9.0%
Tremor 8.2%
Vomiting 5.6%
Completed Suicide 5.2%
Vertigo 4.3%
Tearfulness 4.1%
Weight Decreased 3.4%
Weight Increased 3.4%
Drug Ineffective 2.8%
Persistent Foetal Circulation 2.6%
Maternal Drugs Affecting Foetus 2.4%
Drug Exposure During Pregnancy 2.2%
Paraesthesia 2.2%
Suicide Attempt 2.2%
Cardio-respiratory Arrest 1.7%
Respiratory Distress 1.7%
Visual Disturbance 1.7%
Multiple Congenital Abnormalities 1.5%
Secondary
Depression 29.0%
Product Used For Unknown Indication 19.5%
Drug Use For Unknown Indication 18.9%
Anxiety 10.1%
Emphysema 3.0%
Atrial Fibrillation 2.4%
Hypertension 1.8%
Insomnia 1.8%
Panic Attack 1.8%
Major Depression 1.7%
Obsessive-compulsive Disorder 1.6%
Parkinson's Disease 1.3%
Pain 1.2%
Epilepsy 1.2%
Arrhythmia 1.1%
Ill-defined Disorder 1.1%
Anxiety Disorder 0.7%
Personality Disorder 0.7%
Pregnancy 0.7%
Bipolar Disorder 0.6%
Ventricular Septal Defect 17.4%
Drug Exposure During Pregnancy 9.0%
Suicidal Ideation 8.4%
Withdrawal Syndrome 7.4%
Completed Suicide 6.0%
Tonic Convulsion 6.0%
Vomiting 5.4%
Talipes 4.7%
Intentional Overdose 4.3%
Tremor 4.3%
Weight Increased 4.0%
Multiple Congenital Abnormalities 3.3%
Neuroleptic Malignant Syndrome 3.0%
Treatment Noncompliance 3.0%
Vision Blurred 2.7%
Drug Ineffective 2.3%
Muscle Contractions Involuntary 2.3%
Self Injurious Behaviour 2.3%
Mitral Valve Stenosis 2.0%
Patent Ductus Arteriosus 2.0%
Concomitant
Product Used For Unknown Indication 18.0%
Drug Use For Unknown Indication 13.4%
Prophylaxis 10.6%
Depression 10.3%
Aplastic Anaemia 7.2%
Hypertension 5.7%
Anxiety 4.6%
Rheumatoid Arthritis 4.4%
Hiv Infection 4.1%
Pain 3.4%
Infection Prophylaxis 3.2%
Insomnia 2.6%
Prophylaxis Against Gastrointestinal Ulcer 2.0%
Antiviral Prophylaxis 1.9%
Anxiety Disorder 1.7%
Schizophrenia 1.7%
Constipation 1.6%
Blood Cholesterol Increased 1.4%
Crohn's Disease 1.2%
Back Pain 1.1%
Vomiting 9.7%
Weight Increased 7.8%
Granulocytopenia 6.8%
Tremor 6.8%
Suicide Attempt 6.3%
White Blood Cell Count Decreased 6.3%
Pyrexia 5.3%
Somnolence 5.3%
Type 2 Diabetes Mellitus 4.9%
Thrombocytopenia 4.4%
Vertigo 4.4%
Weight Decreased 4.4%
Renal Failure Acute 3.9%
Intentional Overdose 3.4%
Malaise 3.4%
Neuropathic Ulcer 3.4%
Rash 3.4%
Suicidal Ideation 3.4%
Treatment Noncompliance 3.4%
White Blood Cell Count Increased 3.4%
Interacting
Depression 29.7%
Product Used For Unknown Indication 18.9%
Chronic Obstructive Pulmonary Disease 8.1%
Atrial Fibrillation 5.4%
Back Pain 5.4%
Contraception 5.4%
Hypertension 5.4%
Insomnia 5.4%
Anxiety 2.7%
Blood Cholesterol Increased 2.7%
Coronary Artery Disease 2.7%
Feeling Abnormal 2.7%
Osteoporosis 2.7%
Smoking Cessation Therapy 2.7%
Psychotic Behaviour 27.3%
Chest Pain 18.2%
Back Pain 9.1%
Electrocardiogram Repolarisation Abnormality 9.1%
Renal Failure 9.1%
Serotonin Syndrome 9.1%
Speech Disorder 9.1%
Tobacco User 9.1%